Cargando…
Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside
Glioblastoma (grade IV glioma) is the most aggressive histopathological subtype of glial tumors with inordinate microvascular proliferation as one of its key pathological features. Extensive angiogenesis in the tumor microenvironment supplies oxygen and nutrients to tumoral cells; retains their surv...
Autores principales: | Shamshiripour, Parisa, Hajiahmadi, Fahimeh, Lotfi, Shahla, Esmaeili, Niloofar Robab, Zare, Amir, Akbarpour, Mahzad, Ahmadvand, Davoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231436/ https://www.ncbi.nlm.nih.gov/pubmed/35757736 http://dx.doi.org/10.3389/fimmu.2022.859633 |
Ejemplares similares
-
Immunotherapy for Recurrent Glioma—From Bench to Bedside
por: Pu, Yi, et al.
Publicado: (2023) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Bench and Bedside
por: Schmidt, Christian
Publicado: (2002) -
Gene therapies for high-grade gliomas: from the bench to the bedside
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice
por: Hajiahmadi, Fahimeh, et al.
Publicado: (2019)